(S,S)-formoterol increases the production of IL-4 in mast cells and the airways of a murine asthma model

International Archives of Allergy and Immunology

Volumn 133, Issue 4, 2004, Pages 380-388

  Abraha, Daniel ^a   Cho, Seong H ^a   Agrawal, Devendra K ^b   Park, Jae M ^a   Oh, Chad K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

(R,R) formoterol; (S,S) formoterol; Interleukin 4; Mast cells

Indexed keywords

CALCIMYCIN; CALCIUM IONOPHORE; FORMOTEROL; HISTAMINE; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 4; OVALBUMIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN D2;

ALLERGIC ASTHMA; ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS OBSTRUCTION; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HYPOTHESIS; INTERMETHOD COMPARISON; LEUKEMIA CELL LINE; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTIC INFILTRATION; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RECEPTOR AFFINITY;

ANIMALS; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHODILATOR AGENTS; DISEASE MODELS, ANIMAL; ETHANOLAMINES; HISTAMINE RELEASE; HISTOCYTOCHEMISTRY; HUMANS; INTERLEUKIN-4; JURKAT CELLS; LUNG; MALE; MAST CELLS; METHACHOLINE CHLORIDE; MICE; MICE, INBRED BALB C; PROSTAGLANDIN D2; STEREOISOMERISM; T-LYMPHOCYTES;

EID: 1842862783     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077358     Document Type: Article

References (27)

1. Dutta EJ, Li JT: Beta-agonists. Med Clin North Am 2002;86:991-1008.
2. 2-agonist therapy in asthma. Am J Respir Crit Care Med 2001;164:923-932.
3. Handley DA, Senanayake CH, Dutczak W, Benovic JL, Walle T, Penn RB, Wilkinson HS, Tanoury GJ, Andersson RG, Johansson F, Morley J: Biological actions of formoterol isomers. Pulm Pharmacol Ther 2002;15:135-145.
4. Ameredes BT, Hershman KL, Brown D, Dixon-McCarthy B, Calhoun WJ: GM-CSF production by human airway smooth muscle cells treated with (R,R)- and (S,S)-enantiomers of formoterol. Am J Respir Crit Care Med 2001;179:513S.
5. Cho SH, Hartleroad JY, Oh CK: (S)-albuterol increases the production of histamine and IL-4 in mast cells. Int Arch Allergy Immunol 2001;124:478-484.
6. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST: Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-480.
7. Rothenberg ME, Luster AD, Leder P: Murine eotaxin: An eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA 1995;92:8960-8964.
8. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, Newman W, Luscinskas FW, Gimbrone MA Jr, McIntyre BW: IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 1992;148:1086-1092.
9. Kuhn R, Rajewsky K, Muller W: Generation and analysis of interleukin-4-deficient mice. Science 1991;254:707-710.
10. Hines C: The diverse effects of mast cell mediators. Clin Rev Allergy Immunol 2002;22:149-160.
11. Huels C, Germann T, Goedert S, Hoehn P, Koelsch S, Hultner L, Palm N, Rude E, Schmitt E: Co-activation of naive CD4+ T cells and bone marrow-derived mast cells results in the development of Th2 cells. Int Immunol 1995;7:525-532.
12. Young JD, Liu CC, Butler G, Cohn ZA, Galli SJ: Identification, purification and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc Natl Acad Sci USA 1987;84:9175-9179.
13. Butterfield JH, Weiler D, Dewald G, Gleich GJ: Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988;12:345-355.
14. Oh CK, Ariue B, Tam SW, Cho SH: Effect of the plasminogen activator inhibitor-1 gene in the development of murine asthma. Biochem Biophys Res Commun 2002;294:1155-1160.
15. Cataldo DD, Tournoy KG, Vermaelen K, Munaut C, Foidart JM, Louis R, Noel A, Pauwels RA: Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am J Pathol 2002;161:491-498.
16. Hopfenspirger MT, Agrawal DK: Airway hyperresponsiveness, late allergic response and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J Immunol 2002;168:2516-2522.
17. Moller A, Henz BM, Grutzkau A, Lippert U, Aragane Y, Schwarz T, Kruger-Krasagakes S: Comparative cytokine gene expression: Regulation and release by human mast cells. Immunology 1998;93:289-295.
18. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE: Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores. Nature 1989;339:64-67.
19. Butchers PR, Vardey CJ, Johnson M: Salmeterol: A potent and long-acting inhibitor of inflammatory mediator release from human lung. Br J Pharmacol 1991;104:672-676.
20. 2-agonists: Inhibition of TNF-α release from human mast cells. J Allergy Clin Immunol 1997;100:825-831.
21. 2-adrenoceptor agonists on mast cells of rat, guinea pig and human. Int Arch Allergy Immunol 1994;105:177-180.
22. Choy DK, Ko F, Li ST, Ip LS, Leung R, Hui D, Lai KN, Lai CK: Effects of theophylline, dexamethasone and salbutamol on cytokine gene expression in human peripheral blood CD4+ T-cells. Eur Respir J 1999;14:1106-1112.
23. Ying S, Humbert M, Barkans J, Corrigan CJ, Pfister R, Menz G, Larche M, Robinson DS, Durham SR, Kay AB: Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997;158:3539-3544.
24. Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB: Phenotype of cells expressing mRNA for TH2-type (interleukin-4 and interleukin-5) and TH1-type (interleukin-2 and interferon-γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol 1995;12:477-487.
25. Wallin A, Sandstrom T, Soderberg M, Howarth P, Lundback B, Della-Cioppa G, Wilson S, Judd M, Djukanovic R, Holgate S, Lindberg A, Larssen L, Melander B: The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma. Am J Respir Crit Care Med 1999;159:79-86.
26. Spoelstra FM, Kauffman HF, Hovenga H, Noordhoek JA, de Monchy JG, Postma DS: Effects of budesonide and formoterol on eosinophil activation induced by human lung fibroblasts. Am J Respir Crit Care Med 2000;162:1229-1234.
27. Xie QM, Chen JQ, Shen WH, Yang QH, Bian RL: Comparison of bronchodilating and antiinflammatory activities of oral formoterol and its (R,R)-enantiomers. Acta Pharmacol Sin 2003;24:277-282.